Skip to main content

Research Repository

Advanced Search

TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research Sep 1, 2017 - Dec 31, 2026
The death rate is higher in Yorkshire than the rest of England resulting in about 200 extra deaths each year of which more than half are in Hull. There are other significant cancer outcome inequalities between different groups; for example poorer pe... Read More about TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research.

PEOPLE: Primary care and community Engagement to Optimise time to Presentation with Lung cancEr symptoms in HULL Jun 1, 2017 - Jun 30, 2023
More people are diagnosed with and die from lung cancer in Hull than any other place in Yorkshire. Our aim is to improve earlier diagnosis of lung cancer by [1] getting people to see their doctor if they get lung symptoms and [2] getting GPs to refe... Read More about PEOPLE: Primary care and community Engagement to Optimise time to Presentation with Lung cancEr symptoms in HULL.

CANAssess: Reducing inequalities in care for people with cancer and palliative care needs: a programme of work for cancer patients and caregivers in the community based in Yorkshire Sep 1, 2016 - Jan 30, 2019
People with cancer need good access to palliative care to relieve distressing symptoms, but some get better access than others. Developed in Australia, the Needs Assessment Tool - Progressive Disease Cancer (NAT:PD-C) is a tested, "everyday practice"... Read More about CANAssess: Reducing inequalities in care for people with cancer and palliative care needs: a programme of work for cancer patients and caregivers in the community based in Yorkshire.

NAT ILD: The adaption and validation of an assessment tool to identify the palliative care needs of people with irreversible idiopathic interstitial lung disease for use in every day clinical practice Jun 1, 2014 - Oct 31, 2016
To adapt and validate a needs assessment tool that is fit for purpose in every day clinical practice with regard to the identification of supportive and palliative needs of people with idiopathic pulmonary fibrosis (IPF), and triage those requiring r... Read More about NAT ILD: The adaption and validation of an assessment tool to identify the palliative care needs of people with irreversible idiopathic interstitial lung disease for use in every day clinical practice.

MABEL: A Parallel Group, Double-blind, Randomised Placebo-controlled Trial Comparing The Efficacy And Cost effectiveness Mar 1, 2019 - Feb 29, 2024
A parallel group, double-blind, randomised placebo-controlled trial comparing the efficacy and cost effectiveness of low dose oral modified release morphine (MRM) versus placebo on the intensity of breathlessness and daily activity in people with c... Read More about MABEL: A Parallel Group, Double-blind, Randomised Placebo-controlled Trial Comparing The Efficacy And Cost effectiveness.